在COVID-19后阻塞性睡眠呼吸暂停:一项观察性研究
George-Cosmin Popovici1,2, Costinela-Valerica Georgescu3,4, Mihaela-Camelia Vasile1,5
1School for Doctoral Studies in Biomedical Sciences, "Dunarea de Jos" University from Galati, 800008 Galati, Romania.
Life (Basel, Switzerland)
|August 29, 2024
概括
住院COVID-19患者经常出现严重阻塞性睡眠呼吸暂停 (OSA). 风险因素包括男性性别,60岁以上,肥胖和心血管问题,需要进一步制定睡眠障碍管理策略.
科学领域:
- 肺部病理学 肺部病理学
- 睡眠医学 睡眠医学
- 传染性疾病 传染性疾病
背景情况:
- 严重的COVID-19和阻塞性睡眠呼吸暂停 (OSA) 的危险因素有共同点.
- 包括睡眠障碍在内的COVID-19后并发症需要进一步调查.
- 了解COVID-19住院和OSA之间的联系对于患者管理至关重要.
研究的目的:
- 确定罗马尼亚东南部因COVID-19住院的成年患者中阻塞性睡眠呼吸暂停 (OSA) 的患病率.
- 确定有助于OSACOVID-19后住院治疗发展的相关因素.
- 为了告知临床实践和未来的研究方向,以管理后COVID-19患者的睡眠障碍.
主要方法:
- 一项随访研究涉及2021-2022年期间因COVID-19住院的成年患者.
- 使用爱普沃思和STOP-BANG问卷对OSA进行评估,并进行夜间测谎仪监测.
- 评估是在COVID-19住院后12周进行的.
主要成果:
- 在331名患者中,257人被评估是否有睡眠呼吸暂停.
- 严重阻塞性睡眠呼吸暂停 (OSA) 的高患病率为57.97%.
- 发现的显著关联包括男性性别,年龄超过60岁,肥胖和心血管并发症.
结论:
- 严重的OSA在因COVID-19住院的患者中非常普遍.
- 男性性别,年龄较大,肥胖和心血管相关疾病是关键相关因素.
- 建议包括非侵入性呼吸器治疗 (NIV) 和生活方式修改;需要进一步的诊断和监测策略.
相关概念视频
Sleep Apnea
131
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
131
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Hyperpnea and Hyperventilation
992
Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
992
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Other Pulmonary Disorders
807
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
807


